Serum Levels of Infliximab Biosimilar in a Child Delivered From a Mother Treated for Ulcerative Colitis-Reference-Cited by-同舟云学术

Serum Levels of Infliximab Biosimilar in a Child Delivered From a Mother Treated for Ulcerative Colitis

Published:2022-06-14 Issue:8 Volume:28 Page:1298-1299
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Kawamoto Ami¹^ORCID,Fujii Toshimitsu¹²,Mitani Ryuji³,Suzuki Yasuhiro⁴,Yauchi Tsunehito²,Okamoto Ryuichi¹^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University , Tokyo , Japan

2. Department of Gastroenterology, Soka Municipal Hospital , Soka City , Japan

3. Department of Obstetrics and Gynecology , Yoshinogawa Medical Center , Yoshinogawa City , Japan

4. Department of Gastroenterology, Tokushima Prefectural Central Hospital , Tokushima City , Japan

Abstract

Lay Summary The infliximab biosimilar CT-P13 is used for the treatment of ulcerative colitis. We report for the first time the serum drug levels and long-term health status of the child of a patient treated with CT-P13 throughout her pregnancy.

Funder

Nippon Kayaku Co. Ltd

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

https://academic.oup.com/ibdjournal/advance-article-pdf/doi/10.1093/ibd/izac111/44062678/izac111.pdf

Reference6 articles.

1. Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003–2006.;Bortoli;Alimentary Pharmacology & Therapeutics.,2011

2. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders.;Magro;Journal of Crohn’s and Colitis.,2017

3. Efficacy of infliximab biosimilar CT-P13 induction therapy on mucosal healing in ulcerative colitis.;Farkas;Journal of Crohn’s and Colitis.,2016

4. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn.;Vasiliauskas;Clin Gastroenterol Hepatol.,2006

5. Placental transfer of anti–tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.;Mahadevan;Clin Gastroenterol Hepatol.,2013